Evidence map›Paper›PMID 39318470›Full record

ArticleFrontiers in cellular neuroscience2024

Crystallin β-b2 promotes retinal ganglion cell protection in experimental autoimmune uveoretinitis.

Dirk Bauer, Michael R R Böhm, Xiaoyu Wu, Bo Wang, Tida Viola Jalilvand, Martin Busch, Maren Kasper, Katrin Brockhaus, Lena Wildschütz, Harutyun Melkonyan and 4 more

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dirk Bauer *Department of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Michael R R Böhm *Department of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Xiaoyu WuDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Bo WangDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Tida Viola JalilvandDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Martin BuschDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Maren KasperDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Katrin BrockhausInstitute for Experimental Ophthalmology, Westfalian-Wilhelms-University of Münster, Münster, Germany.
Lena WildschützDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Harutyun MelkonyanInstitute for Experimental Ophthalmology, Westfalian-Wilhelms-University of Münster, Münster, Germany.
Björn LafferDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Gerd Meyer Zu HörsteDepartment of Neurology, University Hospital Münster, Münster, Germany.
Arnd HeiligenhausDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus Hospital, Münster, Germany.
Solon ThanosInstitute for Experimental Ophthalmology, Westfalian-Wilhelms-University of Münster, Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crystallin βb2 (crybb2) is upregulated in regenerating retinas and in various pathological conditions of the retina, including uveoretinitis. However, the role of crybb2 in this disease is largely unknown. Therefore, we used recombinant crybb2 (rcrybb2) as intravitreal treatment of B10.RIII mice prior to immunization with human interphotoreceptor retinoid-binding protein peptide 161-180 (hIRBPp161-180) in complete Freund's adjuvant (CFA) and concomitant injection of pertussis toxin (PTX) to induce experimental autoimmune uveoretinitis (EAU). In naïve mice, more beta III-tubulin (TUBB3) + and RNA-binding protein with multiple splicing (RBPMS) + cells were found in the ganglion cell layer of the retina than in EAU eyes, suggesting a loss of retinal ganglion cells (RGC) during the development of EAU. At the same time, the number of glial fibrillary acidic protein (GFAP) + cells increased in EAU eyes. RGCs were better protected in EAU eyes treated with rcrybb2, while the number of GFAP+ cells decreased. However, in retinal flatmounts, both retinal ganglion cells and retinal endothelial cells stained positive for TUBB3, indicating that TUBB3 is present in naïve B10.RIII mouse eyes not exclusive to RGCs. A significant decline in the number of RBPMS-positive retinal ganglion cells was observed in retinal flatmounts from EAU retinas in comparison to naïve retinas or EAU retinas with intravitreal rcrybb2 treatment. Whereas no significant decrease in TUBB3 levels was detected using Western blot and RT-qPCR, GFAP level, as a marker for astrocytes, increased in EAU mice compared to naïve mice. Level of

Indexed as

apoptosiscrystallin β-b2experimental autoimmune uveitisneuroprotectionretinal ganglion cell

Identifiers

PMID39318470
PMCPMC11419989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.